Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.87 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.69 |
| ▸ | NAAA | Q02083 | 1/20 | 0.65 |
| ▸ | PAM | P19021 | 2/20 | 0.64 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.64 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.64 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.64 |
| ▸ | HTR2C | P28335 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 4/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL677132 | 1.00 | DGKA (0.87) | DGKADNM1NAAAPAMPRSS1 | |
| SCHEMBL21044701 | 1.00 | DGKA (0.87) | DGKADNM1NAAAPAMPRSS1 | |
| SCHEMBL542897 | 1.00 | DGKA (0.87) | DGKADNM1NAAAPAMPRSS1 | |
| SCHEMBL2396240 | 1.00 | DGKA (0.87) | DGKADNM1NAAAPAMPRSS1 | |
| Decane SCHEMBL20893697 | 1.00 | DGKA (0.87) | DGKADNM1NAAAPAMPRSS1 | |
| SCHEMBL21044727 | 1.00 | DGKA (0.87) | DGKADNM1NAAAPAMPRSS1 | |
| SCHEMBL4301741 | 1.00 | DGKA (0.87) | DGKADNM1NAAAPAMPRSS1 | |
| SCHEMBL7750961 | 1.00 | DGKA (0.87) | DGKADNM1NAAAPAMPRSS1 | |
| SCHEMBL8444191 | 1.00 | DGKA (0.87) | DGKADNM1NAAAPAMPRSS1 | |
| SCHEMBL11359267 | 1.00 | DGKA (0.87) | DGKADNM1NAAAPAMPRSS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 214 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12428360-B2 | Abating unwanted emulsion polymerization during extractive distillation of conjugated diene monomers | ECOLAB USA INC. (US) | 2025-09-30 | — | — | US | claimed |
| CN-115023215-B | Formulation providing long-lasting fragrance performance | 弗门尼舍有限公司 | 2025-03-21 | — | — | CN | claimed |
| CN-119013243-A | Reduction of unwanted emulsion polymerization during extractive distillation of conjugated diene monomers | 埃科莱布美国股份有限公司 | 2024-11-22 | — | — | CN | claimed |
| EP-4356894-A1 | SUSTAINABLE PRODUCT WITH MALODORS | Beiersdorf AG (DE) | 2024-04-24 | — | — | EP | claimed |
| CN-111170941-A | Preparation method of 1-cyclopropyl-6, 7-difluoro-8-methoxy fluoroquinolone-3-carboxylic ester | 江西农业大学 | 2020-05-19 | — | — | CN | claimed |
| EP-2282991-B1 | METHOD FOR THE PRODUCTION OF 1,4-BENZOTHIEPIN-1,1-DIOXIDE DERIVATIVES | SANOFI AVENTIS DEUTSCHLAND (DE) | 2018-01-24 | — | — | EP | claimed |
| US-20110245486-A1 | METHOD FOR THE PRODUCTION OF 1,4-BENZOTHIEPIN-1,1-DIOXIDE DERIVATIVES | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2011-10-06 | — | — | US | claimed |
| US-7833957-B2 | Removing solution | DAIKIN INDUSTRIES, LTD. (JP) | 2010-11-16 | — | — | US | claimed |
| US-20060138399-A1 | Removing solution | DAIKIN INDUSTRIES, LTD. (JP) | 2006-06-29 | — | — | US | claimed |
| CN-1678961-A | Removing solution | DAIKIN IND LTD (JP) | 2005-10-05 | — | — | CN | claimed |
| EP-1536291-A1 | REMOVING SOLUTION | Daikin Industries, Ltd. (JP) | 2005-06-01 | — | — | EP | claimed |
| EP-4529924-B1 | TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING CYTISINE | LTS LOHMANN THERAPIE SYSTEME AG (DE) | 2026-02-18 | — | — | EP | disclosed |
| US-12419822-B2 | Compositions based on alkanes and ester(s) with temperature storage stability, use thereof as softening agents and emulsions comprising same | TOTALENERGIES ONETECH (FR) | 2025-09-23 | — | — | US | disclosed |
| EP-4583177-A1 | METHOD OF MANUFACTURING ELECTRODE, COMPOSITE ELECTRODE, ELECTROCHEMICAL ELEMENT, AND APPARATUS FOR MANUFACTURING ELECTRODE | Ricoh Company, Ltd. (JP) | 2025-07-09 | — | — | EP | disclosed |
| WO-2025068549-A1 | TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING CYTISINE | LTS LOHMANN THERAPIE-SYSTEME AG (DE) | 2025-04-03 | — | — | WO | disclosed |
| US-4112083-A | NEMATOCIDE, INSECTICIDE, MITICIDE, FUNGICIDE | ROHM AND HAAS COMPANY (US) | 1978-09-05 | — | — | US | disclosed |
| US-4053499-A | PESTICIDES | ROHM AND HAAS COMPANY (US) | 1977-10-11 | — | — | US | disclosed |
| US-4008319-A | O,S-dialkyl O-benzoyl-phenyl phosphorothiolates and phosphorodithioates, pesticidal compositions and methods of use | ROHM AND HAAS COMPANY (US) | 1977-02-15 | — | — | US | disclosed |
| US-3992423-A | Production of carboxylic acids from olefins with a zeolite in aluminum hydrosol catalysts | UNIVERSAL OIL PRODUCTS COMPANY (US) | 1976-11-16 | — | — | US | disclosed |
| US-3975420-A | PESTICIDE | ROHM AND HAAS COMPANY (US) | 1976-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110245486-A1 | METHOD FOR THE PRODUCTION OF 1,4-BENZOTHIEPIN-1,1-DIOXIDE DERIVATIVES | BBOX1, SULT1E1, PTGS1 | DGKA 3036/4885DNM1 1428/4885NAAA 401/4885 |
| US-12428360-B2 | Abating unwanted emulsion polymerization during extractive distillation of conjugated diene monomers | DDT, PLD1, PNMT | DGKA 11/4885DNM1 80/4885NAAA 1282/4885 |
| US-12419822-B2 | Compositions based on alkanes and ester(s) with temperature storage stability, use thereof as softening agents and emulsions comprising same | ACOX3, ELOVL3, ACOX1 | DGKA 603/4885DNM1 4288/4885NAAA 935/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.